Swissnet Group has announced its preliminary unaudited financial results for FY2024, showcasing significant growth aligned with previous guidance. The company's revenue reached CHF 13.1 million, ...

Accor, the global hospitality leader, has announced the successful completion of the first tranche of its share buyback program. Launched on March 6, 2025, this tranche involved a financial commitment ...

Europlasma, a major player in pollution control and decarbonization, has commissioned SAO Advisors GmbH to find strategic financial and industrial partners. This decision comes amid strong growth in ...

The Vanguard Group, Inc. has disclosed its significant stake in Dalata Hotel Group plc as part of compliance with Rule 8.3 of the Irish Takeover Panel Act, 1997. This disclosure reveals that The ...

The Vanguard Group, Inc. has filed a Form 8.3 relating to Mural Oncology plc. The disclosure, submitted under the Irish Takeover Panel Act, reveals The Vanguard Group holds a significant interest, ...

The Vanguard Group, Inc. has revealed its stake in Direct Line Insurance Group plc, amounting to 5.44% of the company’s ordinary shares. This disclosure is part of their compliance with Rule 8.3 of ...

Hong Kong Science and Technology Parks Corporation (HKSTP) has announced a three-year strategic partnership with Würth Elektronik, marking a significant development in Hong Kong's manufacturing sector ...

Amundi Physical Metals plc has issued the final terms for its series of Amundi Physical Gold ETC Securities. The issuance includes 10,000 ETC Securities, part of Tranche 699 under the Secured Precious ...

Amundi Physical Metals plc announced the final terms for the issuance of 10,000 ETC Securities as part of its Amundi Physical Gold ETC program. This tranche, numbered 699, adds to an aggregate of ...

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock ...

Secarna Pharmaceuticals will present new data on its leading antisense oligonucleotide program, SECN-15, at the upcoming ASCO Annual Meeting in Chicago. SECN-15 targets Neuropilin-1, presenting a ...

On May 23, 2025, NFL Biosciences announced the successful completion of a capital increase, capped at €3 million. The biopharmaceutical company secured €2.4 million from qualified international and ...